Suchergebnisse - "Follmann, Dean"

PubPharm (13)

1

Four statistical frameworks for assessing an immune correlate of protection (surrogate endpoint) from a randomized, controlled, vaccine efficacy trial

enthalten in: Vaccine | 2024

von Gilbert, P. | Fong, Y. | Hejazi, N. | +5

2

Stochastic interventional approach to assessing immune correlates of protection : Application to the COVE messenger RNA-1273 vaccine trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Hejazi, N. | Shen, X. | Carpp, L. | +10

3

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults : a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2023

von Dayan, G. | Rouphael, N. | Walsh, S. | +120

4

Vaccine efficacy at a point in time

enthalten in: Biostatistics (Oxford, England) | 2023

von Follmann, D. | Fay, M.

5

Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials

enthalten in: JAMA network open | 2023

von Mena Lora, A. | Long, J. | Huang, Y. | +125

ErratumIn: JAMA Netw Open. 2023 May 1;6(5):e2317317. - PMID 37213108

6

A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines

enthalten in: The New England journal of medicine | 2022

von Gilbert, P. | Donis, R. | Koup, R. | +3

7

Assessing vaccine durability in randomized trials following placebo crossover

enthalten in: Statistics in medicine | 2021

von Fintzi, J. | Follmann, D.

8

A unified evaluation of differential vaccine efficacy

enthalten in: Biometrics | 2020

von Gabriel, E. | Sachs, M. | Follmann, D. | +1

9

Sieve analysis using the number of infecting pathogens

enthalten in: Biometrics | 2018

von Follmann, D. | Huang, C.

10

Incorporating founder virus information in vaccine field trials

enthalten in: Biometrics | 2015

von Follmann, D. | Huang, C.